Eli Lilly (LLY) Dividends Paid - Common (2009 - 2026)

Eli Lilly has reported Dividends Paid - Common for 18 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Dividends Paid - Common rose 15.01% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $5.6 billion (up 15.01% YoY), and the FY2025 full-year result was $5.4 billion, up 15.04% from the prior year.
• Dividends Paid - Common for Q1 2026 stood at $1.5 billion, up from $1.3 billion in the prior quarter.
• The five-year high for Dividends Paid - Common was $2.0 billion in Q2 2023, with the low at $882.2 million in Q3 2022.
• Historically, Dividends Paid - Common has averaged $1.2 billion across 5 years, with a median of $1.2 billion in 2024.
• Annual changes were most pronounced in 2024 — Dividends Paid - Common plunged 42.36% — and 2025, when it increased 15.21%.
• Eli Lilly's Dividends Paid - Common stood at $884.4 million in 2022, then increased by 15.08% to $1.0 billion in 2023, then increased by 14.75% to $1.2 billion in 2024, then increased by 15.21% to $1.3 billion in 2025, then climbed by 15.05% to $1.5 billion in 2026.
• The last three Dividends Paid - Common figures came in at $1.5 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.